Biovail Axes U.S. Commercial Organization, Seeks Promotional Partner For Zovirax
This article was originally published in The Pink Sheet Daily
Executive Summary
With the potential entry of generic Wellbutrin XL looming, Biovail cuts 200-person commercial organization in the U.S.
You may also be interested in...
Biovail Partners with Alexza On Late-Stage CNS Drug For Schizophrenia Agitation
Biovail gets ready to rebuild a U.S. commercial team, while Alexza gets a cash infusion to fund its business through early 2011.
Biovail Partners with Alexza On Late-Stage CNS Drug For Schizophrenia Agitation
Biovail gets ready to rebuild a U.S. commercial team, while Alexza gets a cash infusion to fund its business through early 2011.
Zovirax Sales Force To Increase Six Fold Based On Biovail Agreement With Sciele
Promotional deal includes profit-sharing arrangement based on revenue targets for an initial term of five years.